MOLN
$3.91
Revenue | $1.03Mn |
Net Profits | $-19.78Mn |
Net Profit Margins | -1916.67% |
Molecular Partners Ag -adr’s revenue fell -61.68% since last year same period to $1.03Mn in the Q4 2023. On a quarterly growth basis, Molecular Partners Ag -adr has generated -59.39% fall in its revenue since last 3-months.
Molecular Partners Ag -adr’s net profit jumped 0.63% since last year same period to $-19.78Mn in the Q4 2023. On a quarterly growth basis, Molecular Partners Ag -adr has generated -72.92% fall in its net profits since last 3-months.
Molecular Partners Ag -adr’s net profit margin fell -159.31% since last year same period to -1916.67% in the Q4 2023. On a quarterly growth basis, Molecular Partners Ag -adr has generated -325.76% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.97 |
EPS Estimate Current Year | -0.97 |
Molecular Partners Ag -adr’s earning per share (EPS) estimates for the current quarter stand at -0.97 - a -Inf% fall from last quarter’s estimates.
Molecular Partners Ag -adr’s earning per share (EPS) estimates for the current year stand at -0.97.
Earning Per Share (EPS) | -0.68 |
Return on Assets (ROA) | -0.17 |
Return on Equity (ROE) | -0.3 |
Molecular Partners Ag -adr’s earning per share (EPS) fell -25.67% since last year same period to -0.68 in the Q4 2023. This indicates that the Molecular Partners Ag -adr has generated -25.67% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Molecular Partners Ag -adr’s return on assets (ROA) stands at -0.17.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Molecular Partners Ag -adr’s return on equity (ROE) stands at -0.3.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-06-30 | -0.87 | -0.54 | 37.74% |
2024-03-14 | -0.97 | -0.68 | 30.04% |
2023-09-30 | 0 | -0.39 | -Inf% |
2023-05-12 | 0 | -0.49 | -Inf% |